Administration of β-carotene (20, 40 and 60 mg/kg) dose-dependently significantly increased peripheral blood WBC, TP, ALB and A/G in β-carotene-treated groups (p < 0.01) compared to untreated HCC rats. This evidence concerns the gene ALB and hepatocellular carcinoma.